Detail akcie Hologic Inc online

Business Summary: Hologic, Inc. is a medical technology company primarily focused on improving women's health and well-being through early detection and treatment. The Company is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products. It operates through four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The Diagnostics segment offers a wide range of diagnostic products, which are used primarily to aid in the screening and diagnosis of human diseases. The Breast Health segment offers a broad portfolio of solutions for breast cancer care primarily in the areas of radiology, breast surgery, pathology and treatment. The GYN Surgical segment products include MyoSure hysteroscopic tissue removal system, NovaSure endometrial ablation system, Fluent fluid management system and Acessa ProVu laparoscopic radiofrequency ablation system. The Skeletal Health segment products include Horizon DXA Systems and Fluoroscan Insight FD.
Financial Summary: BRIEF: For the three months ended 30 December 2023, Hologic Inc revenues decreased 6% to $1.01B. Net income increased 32% to $246.5M. Revenues reflect Diagnostics segment decrease of 20% to $447.8M, Skeltal Health segment decrease of 5% to $25.4M, United States segment decrease of 8% to $753.7M, Europe segment decrease of 3% to $142.8M. Net income reflects Breast Health segment income increase of 69% to $102.2M.